1832 Asset Management L.P. Illumina, Inc. Transaction History

1832 Asset Management L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$128.91 - $192.44 $18.4 Million - $27.5 Million	143,000 New	143,000 $19.6 Million
Q2 2023 Aug 11, 2023	BUY	$183.43 - $232.67 $733 - $930	4 New	4 $0
Q4 2021 Feb 15, 2022	SELL	$347.28 - $421.83 $365,338 - $443,765	-1,052 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $420,211 - $543,734	1,036 Added 6475.0%	1,052 $436,000
Q2 2021 Aug 16, 2021	BUY	$372.84 - $481.5 $5,965 - $7,704	16 New	16 $8,000
Q1 2020 May 14, 2020	SELL	$209.2 - $335.53 $627 - $1,006	-3 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$288.29 - $335.49 $864 - $1,006	3 New	3 $1,000
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $109 Million - $128 Million	-399,525 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $27.9 Million - $37.5 Million	-102,217 Reduced 20.37%	399,525 $118 Million
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $63.5 Million - $83.5 Million	227,442 Added 82.92%	501,742 $182 Million
Q2 2018 Aug 14, 2018	BUY	$228.17 - $292.07 $56.4 Million - $72.1 Million	247,000 Added 904.76%	274,300 $74.8 Million
Q1 2018 May 15, 2018	BUY	$209.54 - $253.91 $5.72 Million - $6.93 Million	27,300 New	27,300 $6.49 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.